Clinical Trial Update: A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether combining Fianlimab with Cemiplimab improves treatment of recurrent or metastatic head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Status: RECRUITING